# RELEXXII

NDC: 68025-088
Generic name: methylphenidate hydrochloride
Labeler / Manufacturer: Vertical Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20220623

FDA application: NDA216117

## Active ingredients

- METHYLPHENIDATE HYDROCHLORIDE: 45 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68025-088"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68025-088
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d